Ocular Therapeutix Inc. buy Royal Bank of Canada
Start price
18.03.25
/
50%
€6.81
Target price
18.03.26
€15.58
Performance (%)
62.60%
Price
18.12.25
€11.07
Summary
This prediction is currently active. With a performance of 62.60% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 18.03.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ocular Therapeutix Inc. | -11.369% | -11.369% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Ocular Therapeutix Inc.
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€9.41
05.11.25
05.11.25
-
05.11.26
05.11.26
17.69%
18.12.25
18.12.25
